NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹2,291 Cr | ₹1,674 Cr | ₹862 Cr | ₹202 Cr | ₹580 Cr |
What is the latest Profit Before Tax of NATCO PHARMA ?
| Year | Profit Before Tax |
|---|---|
| Mar2025 | ₹2,291 Cr |
| Mar2024 | ₹1,674 Cr |
| Mar2023 | ₹862 Cr |
| Mar2022 | ₹202 Cr |
| Mar2021 | ₹580 Cr |
How is Profit Before Tax of NATCO PHARMA Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,291 Cr | 36.92 | |
| Mar2024 | ₹1,674 Cr | 94.16 | |
| Mar2023 | ₹862 Cr | 326.26 | |
| Mar2022 | ₹202 Cr | -65.11 | |
| Mar2021 | ₹580 Cr | - | |
Compare Profit Before Tax of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,081.1 Cr | 3.5% | 1.1% | -36.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,370.0 Cr | 1.2% | 5.5% | 0.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,802.0 Cr | -1.8% | -3.1% | 8.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,841.0 Cr | -2% | 2.8% | 19.2% | Stock Analytics | |
| CIPLA | ₹121,481.0 Cr | -0.7% | -8.6% | 2.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,220.0 Cr | -1.5% | -4.3% | 2.5% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 3.5% |
1.1% |
-36.7% |
| SENSEX | -0.1% |
0.6% |
9.8% |
You may also like the below Video Courses